Mitochondrial Nadh Dehydrogenase Subunit 3 Polymorphism Associated With An Earlier Age At Onset In Male Machado-Joseph Disease Patients

Sheng Chen,Shi-Rui Gan,Ping-Ping Cai,Wang Ni,Qi Zhou,Yi Dong,Ning Wang,Zhi-Ying Wu
DOI: https://doi.org/10.1111/cns.12443
2016-01-01
CNS Neuroscience & Therapeutics
Abstract:Aims: To investigate the potential effect of six previously reported candidate single nucleotide polymorphisms on age at onset (AAO) among Chinese patients with Machado-Joseph disease (MJD). Methods: Three hundred and twenty-four unrelated molecular-confirmed MJD patients were recruited between January 2006 and December 2014. The screening of candidate polymorphisms was first performed in 173 subjects using the SNaPshot (R) Multiplex System. The mitochondrial NADH dehydrogenase subunit 3 (MT-ND3) polymorphism 10398A>G (rs2853826) was further verified with Sanger sequencing in additional 151 patients. Results: An inverse correlation was found between expanded CAG repeat length and AAO. The expanded CAG repeat length can explain 63% of AAO variance. The 10398A polymorphism was significantly associated with a 3-year earlier AAO in male patients with MJD (P = 0.001). Stepwise multiple regressions revealed that the 10398A polymorphism could account for nearly 2% of AAO variance in male patients. Conclusion: Six candidate SNPs have been screened in Chinese patients with MJD. A remarkable earlier AAO was noted in male Chinese MJD patients with MT-ND3 gene 10398A polymorphism.
What problem does this paper attempt to address?